logo

For the Inventor, By the Inventor

Blaesheim, France

Pierre H Chambon

USPTO Granted Patents = 28 

 

Average Co-Inventor Count = 3.5

ph-index = 10

Forward Citations = 335(Granted Patents)


Location History:

  • Strasbourg, FR (1994)
  • 67085 Strasbourg, FR (1995)
  • Bleasheim, FR (1996)
  • Blaesheim, FR (1993 - 2021)

Company Filing History:

goldMedal11 out of 5,089 
 
Centre National De La Recherche Scientifique
 patents
silverMedal8 out of 1,744 
 
Institut National De La Sante Et De La Recherche Medicale
 patents
bronzeMedal6 out of 32 
 
Université Louis Pasteur
 patents
4. 5 out of 3,685 
 
Bristol-myers Squibb Compnay
 patents
5. 3 out of 158 
 
Transgene S.a.
 patents
6. 3 out of 1,624 
 
E. R. Squibb Sons, Inc.
 patents
7. 2 out of 870 
 
Institut Pasteur
 patents
8. 1 out of 1 
 
Gie-cerbm, Centre Europeen De Recherche En Biologie Et En Medecine (gie)
 patent
9. 1 out of 1 
 
Universite Louis Pasteur Strasbourg
 patent
10. 1 out of 1 
 
Association Pour Le Development De La Recherche En Genetique Moleculaire (aderegem)
 patent
11. 1 out of 1 
 
Gie-cerbn, Centre Europeen De Recherche En Biologie Et En Medecine (gie)
 patent
12. 1 out of 2 
 
Université Louis Pasteur Strasbourg I
 patents
13. 1 out of 1 
 
Aderegem
 patent
14. 1 out of 1 
 
Association Pour La Recherche a L'igbmc (ari)
 patent
15. 1 out of 2,345 
 
University of Illinois
 patents
16. 1 out of 170 
 
Universitéde Strasbourg
 patents
17. 6 out of 832,891 
Other
 patents
where one patent can have more than one assignee

Years Active: 1993-2021

Loading Chart...
Loading Chart...
28 patents (USPTO):Explore Patents
1. 11179363 - Non-steroidal selective glucocorticoid receptor agonistic modulators (SEGRAMs) and uses thereof (2021-11-23),
2. 9273115 - Method for controlling the biological activity of a protein in a vertebrate cell (2016-03-01),
3. 7112715 - Transgenic mouse for targeted recombination mediated by modified Cre-ER (2006-09-26),
4. 7074611 - Method for the stable inversion of DNA sequence by site-specific recombination and DNA vectors and transgenic cells thereof (2006-07-11),
5. 6861508 - Transcriptional intermediary factor-2 (2005-03-01),
6. 6699686 - Modified nuclear glucocorticoid receptor, fusion protein, and DNA fragments coding for said receptor and said fusion protein (2004-03-02),
7. 6653322 - Therapeutic combinations of RAR antagonists and RXR agonists and use thereof (2003-11-25),
8. 6635429 - Heterodimeric nuclear receptors proteins, genes encoding same, and usage thereof (2003-10-21),
9. 6521814 - Use of ligands for treatment of diseases responsive to retinoids (2003-02-18),
10. 6486381 - Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins (2002-11-26),
11. 6444438 - Method for the preparation of a protein by yeasts using an inducible system, vectors and correspondence transformed strains (2002-09-03),
12. 6328956 - Pharmaceutical composition for the treatment or prevention of a malignant tumor (2001-12-11),
13. 6268173 - Polynucleotide encoding transcriptional intermediary factor-2 (2001-07-31),
14. 6203795 - Pharmaceutical composition for the treatment or prevention of a malignant tumor (2001-03-20),
15. 6130230 - Therapeutic combinations of RAR antagonists and RXR agonists and use (2000-10-10),

Title: The Innovative Journey of Inventor Pierre H Chambon

Introduction: Pierre H Chambon, a distinguished male inventor hailing from Blaesheim, France, has made significant contributions to the field of innovations and inventions.

Latest Patents: Pierre H Chambon holds several patents in the areas of biotechnology and molecular biology, showcasing his expertise and creativity in these fields.

Career Highlights: Throughout his illustrious career, Pierre H Chambon has been a trailblazer in the scientific community, pioneering groundbreaking research and inventions that have had a lasting impact on the industry.

Collaborations: Pierre H Chambon has collaborated with leading researchers, scientists, and institutions around the world, fostering a culture of innovation and knowledge-sharing in his field.

Conclusion: In conclusion, Pierre H Chambon's dedication to innovation and his remarkable contributions to the world of inventions have solidified his legacy as a visionary inventor in the realm of biotechnology and molecular biology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…